Collectively, our studies suggest that i) UCP2 over-expression in tumors is a common phenomenon; ii) UCP2 over-expression promotes tumor development and iii) UCP2 over-expression can serve as a promising therapeutic target for treatment of breast and many other cancers. This evidence concerns the gene UCP2 and neoplasm.